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In this study, to evaluate the influence of strangles vaccination on serological test results, we
investigated the changes in strangles serum antibody levels in horses after vaccination and
subsequent intranasal challenge with S. equi.  The horses were vaccinated for strangles with
either a component vaccine (Group C) or a live vaccine (Group L).  We measured changes in
strangles serum antibody levels weekly for 20 weeks after vaccinating horses twice for
strangles over a 3-week interval, and for 7 weeks after intranasal challenge with S. equi in the
same horses.  Serum antibody responses to the proline-glutamic acid-proline-lysine (PEPK)
antigen with five repetitions (PEPK-5R) were higher at all times (up to 2.4-fold) following
vaccination in Group C than in Group L, and the value peaked at 2.9-fold above the initial
value after the second vaccination in Group C horses.  However, the value was lower than
that in horses infected with S. equi, and it gradually decreased, reaching the initial (week 0)
value by the 15th week.  Serum antibody responses to PEPK-5R after challenge with S. equi
increased in both groups of horses, but the value tended to be lower than that reported for
unvaccinated horses.  In addition, the average value in Group C was 2.6-fold higher than that
of Group L.  These results suggest the serum antibody responses of horses infected with S.
equi varies according to the type of vaccine with which they have been vaccinated.  Although
the serological diagnostic test for strangles in which PEPK-5R is used as an antigen is
effective for the investigation of serum antibodies to strangles in vaccinated horses, the
present data suggest it is necessary to consider the vaccination history when interpreting the
results.
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Streptococcus equi
Strangles is a contagious disease of the upper
respiratory tract characterized by the abrupt onset of
fever followed by upper respiratory tract catarrh.  In
addition, strangles is characterized by a mucopurulent
nasal discharge and acute swelling with subsequent
abscess  formation in the submandibular and
retropharyngeal lymph nodes [4, 8, 9, 11].  Strangles is
a commonly diagnosed and important infectious
disease of horses worldwide [6].
A serological diagnostic test that could specifically
diagnose strangles would be extremely helpful for its
diagnosis and for undertaking epidemiological surveys.
However, there has not been a sufficiently specific
serological diagnostic assay [3, 12, 13], because sera from
Streptococcus equi subsp. equi (S. equi)-infected horses can
not be defini t ively dist inguished from sera from
S t r e p to c o c c u s  e q u i  s ubsp .  z o o e p id e m i c u s  ( S .
zooepidemicus)-infected horses.  Recently, it has been
reported that an enzyme-linked immunosorbent assay
(ELISA) method using the proline-glutamic acid-proline-
lysine antigen with five repetitions (PEPK-5R) has proven
useful as a serological diagnostic test for strangles (PEPK-
5R-ELISA) [5], and that sera from S. equi-infected horses
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are clearly distinguishable from sera from S. zooepidemicus-
infected horses.  However, that report did not mention the
influence of strangles vaccination on the serological
diagnostic test.  Because strangles vaccines are used
relatively frequently in many countries, it is important to
distinguish in a clinical application of the serological
diagnostic test whether increases in serum antibody levels
are caused by strangles infection or by prior vaccination
against strangles.  Moreover, it is important for the
diagnosis and epidemiological study of strangles to
determine if and how serum antibody levels change in
vaccinated horses after S. equi infection.
In this study, to evaluate the influence of strangles
vaccination on the serological test results, we investigated
changes in strangles serum antibody levels in horses after
vaccination and subsequent intranasal challenge with S.
equi.
Materials and Methods
Vaccine
This study employed a component vaccine (Strepguard®,
Intervet, U.S.A.) and a live vaccine (Pinnacle™ I.N., Fort
Dodge Animal Health, U.S.A.).  Detailed information on
the elements of the component vaccine is unavailable.
Experimental study
The Animal Use and Care Committee and Animal
Welfare and Ethics Committee of the Equine Research
Institute, Japan Racing Association, approved the
protocols for this study.  Six thoroughbreds (1 year old;
five female and one male) were used for this study.
These horses had no history of strangles, and were
clinically confirmed to have been in good health for at
least six months.  The six thoroughbreds were
randomly divided into two groups, horses inoculated
intramuscularly with the component vaccine (horses 1–
3, Group C) and horses inoculated intranasally with the
live vaccine (horses 4–6, Group L).  Both groups were
vaccinated twice, once each at weeks 0 and 3.  Clinical
signs were assessed and nasal cavity swabs and serum
samples were drawn just before and every week
following the vaccination.  The horses were examined
twice a day for clinical signs, such as reduced levels of
appetite, rhinorrhea, coughing, enlarged lymph nodes,
spontaneous rupture of the lymph nodes, abnormal
lung sounds or increased rectal temperature.  Sera and
nasal cavity swabs were obtained from these horses
every week for up to 30 weeks after the initial
vaccination.  
Intranasal challenge with S. equi
The challenge with S. equi was performed by intranasal
inoculation of 1 × 108 colony forming units (CFU) of an
overnight broth culture of S. equi strain CF32 at 23 weeks
after the initial vaccination.  Clinical signs were monitored
and sampling was performed as described above for 7
weeks.  All the horses’ clinical signs were treated with
antipyretics and the horses were rehydrated if necessary.
They were euthanized by an intravenous injection of a
mixture  of  sodium th iopenta l  (Ravonal ,  Tanabe
Pharmaceutical, Osaka, Japan) and suxamethonium chloride
(Relaxin, Kyorin Pharmaceutical, Tokyo, Japan) 7 weeks
after the challenge, and necropsied .
Isolation and PCR examination of S. equi
The nasal cavity swab was suspended in 500 μl of normal
saline solution. S. equi was isolated by inoculating
Colombian agar containing 5% horse blood with 50 μl of the
suspension, and S. equi was identified using API Strep 20
(SYSMEX bioMerieux, Tokyo, Japan).  Total DNA was
extracted from the suspension using InstaGene Matrix
(BIO-RAD, U.S.A.), and the S. equi seM gene was detected
with a semi-nested PCR method [1].  Additionally, the seM
genotype of the isolated S. equi was analyzed as described in
a previous report [2].
Detection of serum antibody to S. equi
The serum antibody to S. equi was detected as described
in a previous report by using PEPK-5R [5].  Briefly,
microtitre plates (MAXISORP, NUNC, Denmark) were
coated with 50 μl/well (in 10 μg/ml of 10 mM phosphate-
buffered saline solution: a large volume of phosphate-
buffered saline (25X®), Lab Vision, U.S.A.) of the
synthesized PEPK-5R (>95% purity).  After blocking (1:4
d i l u t ed  b loc k in g  bu f fe r :  B loc kA ce ,  Da in ip pon
Pharmaceutical), 50 μl samples of diluted (1:100) test sera
(in 1:10 diluted blocking buffer) were added to the wells in
triplicate.  Bound proteins were reacted with horseradish
peroxidase-conjugated anti-horse IgG (H+L) (Goat Anti-
Horse IgG (H+L)-HRP,  Southern Biotechnology
Associates, U.S.A.) in 1:10 diluted blocking buffer.  Color
was detected by adding a substrate solution (Horseradish
Peroxidase Substrate Kit, BIO-RAD, U.S.A.) and the
reaction was stopped by adding 2% oxalic acid (50 μl/well).
The absorbance at 415 nm was measured with an ELISA
reader (Spectrophotometer DU 800, Beckman Coulter,
U.S.A.).  Data are expressed as optical density (OD). 
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Statistical analysis
Optical density values were compared with Student’s t-
test between Group C and L at weeks 0 and 23 to determine
if differences between the groups existed at the start of each
treatment (vaccination or inoculation).  Differences between
pre-vaccination (week 0) and pre-inoculation (week 23) OD
were evaluated with the paired t-test to determine if effects
of the vaccinations persisted at the time of inoculation.
Optical density values were analyzed with 2-way ANOVA
for repeated measures (RMANOVA) between Group C
horses and Group L horses with vaccine and time as factors
for both the post-vaccination interval (weeks 1–23) and the
post-innoculation interval (weeks 24–30).  Values of p<0.05
were considered significant.  The data are expressed as
mean ± SD. 
Results
Clinical observation after vaccination
In the six tested horses, no abnormal clinical findings
were observed following vaccination (Table 1).  In addition,
S. equi was not isolated and the S. equi seM gene was not
detected a week after the vaccinations in the horses (4–6)
inoculated with live vaccine. 
Clinical observation after intranasal challenge with S. equi
Although pyrexia was observed in all horses challenged
with S. equi, only horses 3, 5 and 6 suffered spontaneous
rupture of lymph node (submandibular lymph node)
abscesses (Table 1).  
Postmortem examination
Although swelling of the cranial lymph nodes
(especially the submandibular and retropharyngeal
nodes) was found in all of the tested horses, S. equi was
only isolated from the spontaneously ruptured lymph
nodes (submandibular lymph node) of horses 3, 5 and
6 (Table 1).  In addition, seM gene analyses confirmed
that the isolated S. equi was the inoculated strain, CF32.
OD values of test sera 
Remarkable increases of the antibody level were not seen
in either of the vaccination groups, but changes in
antibody levels were different between them.  Initial
(week 0) OD values for both groups of horses were
comparable: 0.112 ± 0.015 vs. 0.122 ± 0.148 for Groups C
and L, respectively, p=0.91.  The OD of sera from Group C
horses increased 2.9-fold above their initial value after the
second vaccination, with a maximum OD of 0.328 ± 0.186
(Fig. 1).  The OD of Group C horses decreased with time
and returned to their initial (week 0) values in the 15th week
(p=0.89).  Only one horse in Group L showed a slight
increase in OD following the second vaccination, and Group
C OD values were higher at all times following vaccination
than those of Group L, with a maximum difference of 2.4-
fold.  Despite these consistent differences, comparison of
the OD values following the second vaccination and before
inoculation (weeks 4–23) with 2-way RMANOVA detected
no significant difference in the responses to the two
vaccines (p=0.376), although time had a significant effect
(p<0.001) and the vaccine × time interaction (p=0.058)
bordered on significance.
Serum antibody responses to PEPK-5R after challenge
with S. equi increased greatly in both groups of horses, and
the average OD in Group C was 2.6-fold higher than that of
Group L (Fig. 1).  The peak OD occurred in both groups at
4 weeks after innoculation, with mean values of 0.752 ±
0.062 and 0.345 ± 0.169 for Groups C and L, respectively.
Table 1. Clinical examination and postmortem examination findings after vaccination for strangles and intranasal challenge with S.
equi in 6 horses
Group Horse Clinical signs Postmortem examination
 no. after vaccination after challenge abnormal findings isolation of  S. equi
C 1 none EL EL         –
C 2 none Fever (39.3°C), RAc, RAp, Rh, EL EL         –
C 3 none Fever (39.3°C), RAc, RAp, Rh, EL, SRL EL, SRL +
L 4 none EL EL         –
L 5 none Fever (38.5°C), RAc, RAp, Rh, EL, SRL EL, SRL +
L 6 none Fever (40.2°C), RAc, RAp, Rh, EL, SRL EL, SRL +
Group C (horses 1–3) were inoculated the component vaccine.  Group L (horses 4–6) were inoculated the live vaccine.  Fever:
increased rectal temperature (≥38.5°C); RAc: reduced activity; RAp: reduced appetite; Rh: rhinorrhea;  Co: coughing; EL: enlarged
lymph nodes; SRL: spontaneous rupture of lymph nodes; ALS: abnormal lung sounds.
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The 2-way RMANOVA detected a significant difference in
the responses of the horses administered the two vaccines
(p=0.003), but no differences due to time or time × vaccine
interaction, S. equi isolation and the rise of serum antibody
levels.
Discussion
Although serum antibody levels increased in Group
C horses after the second vaccination, the increase was
small, and the highest mean OD-value (0.328) was
lower than the cut-off OD-value (0.427) for normal
horses, the mean + 3 SD of sera from 3,106 uninfected
control horses determined in a previous study [5].  In
addition, the increase in serum antibody levels was
transient in Group C, and it returned to the pre-
vaccination value after 12 weeks.  In Group L, serum
antibody levels for PEPK-5R rose only minimally
following vaccination, and the highest OD value (0.171
± 0.127) was also lower than the cut-off OD value.
Therefore, regarding the two vaccines tested in this
study, vaccinated horses are unlikely to be misidentified
as naturally infected horses by this serological
diagnostic test.
There are other strangles vaccines on the market in
addition to the two used in this study, and their effects and
problems associated with their use have been reported [7,
10, 14].  However, the influence of other vaccines on the
PEPK-5R-ELISA has not yet been investigated.  Further
studies using other vaccines will be necessary for accurate
interpretation of the test results.
Although the challenge with S. equi resulted in some
pathogenesis, the clinical signs were relatively slight,
indicating that the vaccination was effective in suppressing
the clinical signs.  However, in general, vaccination did not
prevent clinical strangles completely, and the development
of a more effective vaccine is needed for the control of this
disease.
The increases in serum antibody responses to PEPK-5R
after challenge with S. equi in this study were slight
(maxima 0.752 ± 0.062 and 0.345 ± 0.169 for Groups C and
L, respectively) compared with those previously reported
for unvaccinated horses challenged with S. equi (OD 1.707
± 0.244) [5].  Serum antibody responses to PEPK-5R of
Group C horses exceeded the cut-off value (0.427) for about
4 weeks after the challenge and the highest OD value
(0.650) previously reported for a single uninfected horse [5].
However, serum antibody responses to PEPK-5R of Group
L horses were even less than the cut-off value (0.427) and
the highest OD value (0.650) [5], although the latter value
falls within the 95% confidence intervals of both Group C
Fig. 1. Alterations in serum antibody levels (measured as optical density) for PEPK-5R in horses vaccinated for S. equi, and after
intranasal challenge with S. equi five months later.  Three horses in Group C (open circles) were inoculated with component
vaccine and three horses in Group L (closed circles) were inoculated with live vaccine.  Both groups were vaccinated at weeks
0 and 3.  Horses were challenged with S. equi in week 23.  Data are expressed as mean ± SD. The time × vaccine interaction
of the post-vaccination response (weeks 4–23) was not significant when tested with 2-way RMANOVA.  The serum antibody
responses in the post-inoculation period (weeks 24–30) were significantly different between the two vaccines when tested with
2-way RMANOVA.
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and Group L means.  These results suggest that it is
important to consider vaccination history when interpreting
serological diagnost ic results in epidemiological
investigations of strangles.  
There was a significant difference in the serological
responses of the two vaccines following the challenge even
though the horses’ clinical signs and postmortem
examinations were similar.  We could not determine in this
study what aspect of the vaccines caused this difference.
In conclusion, the results of this study suggest the
possibility that the increased serum antibody responses
to PEPK-5R in horses infected with S. equi may be
markedly reduced if the animals were previously
vaccinated.  Accurate interpretation of the serological
test results may depend on taking the vaccination
history into consideration.
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